Skip to main content
Top
Published in: Netherlands Heart Journal 4/2016

Open Access 01-04-2016 | Review Article

Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change

Authors: L. J. M. Boonman-de Winter, M. J. Cramer, A. W. Hoes, F. H. Rutten

Published in: Netherlands Heart Journal | Issue 4/2016

Login to get access

Abstract

Undetected heart failure appears to be an important health problem in patients with type 2 diabetes and aged ≥ 60 years. The prevalence of previously unknown heart failure in these patients is high, steeply rises with age, and is overall higher in women than in men. The majority of the patients with newly detected heart failure have a preserved ejection fraction. A diagnostic algorithm to detect or exclude heart failure in these patients with variables from the medical files combined with items from history taking and physical examination provides a good to excellent accuracy. Annual screening appears to be cost-effective. Both unrecognised heart failure with reduced and with preserved ejection fraction were associated with a clinically relevant lower health status in patients with type 2 diabetes. Also the prognosis of these patients was worse than of those without heart failure. Existing disease-management programs for type 2 diabetes pay insufficient attention to early detection of cardiovascular diseases, including heart failure. We conclude that more attention is needed for detection of heart failure in older patients with type 2 diabetes.
Literature
1.
go back to reference Chiasson JL, Le LJ. Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes. Lancet. 2014;384:1906–7.CrossRefPubMed Chiasson JL, Le LJ. Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes. Lancet. 2014;384:1906–7.CrossRefPubMed
2.
go back to reference Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012;55:2154–62.CrossRefPubMedPubMedCentral Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012;55:2154–62.CrossRefPubMedPubMedCentral
3.
go back to reference Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. Efficiently screening heart failure in patients with type 2 diabetes. Eur J Heart Fail. 2015;17:187–95.CrossRefPubMed Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. Efficiently screening heart failure in patients with type 2 diabetes. Eur J Heart Fail. 2015;17:187–95.CrossRefPubMed
4.
go back to reference Boonman-de Winter LJ. Uncovering Heart Failure in Type 2 Diabetes. Utrecht: University Utrecht; 2015. Boonman-de Winter LJ. Uncovering Heart Failure in Type 2 Diabetes. Utrecht: University Utrecht; 2015.
5.
go back to reference Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055–68.CrossRefPubMed Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055–68.CrossRefPubMed
6.
go back to reference Boonman-de Winter LJ, Hoes AW, Cramer MJ, de Jongh G, Janssen RR, Rutten FH. Prognosis of screen-detected heart failure with reduced and preserved ejection fraction in patients with type 2 diabetes. Int J Cardiol. 2015;185:162–4.CrossRefPubMed Boonman-de Winter LJ, Hoes AW, Cramer MJ, de Jongh G, Janssen RR, Rutten FH. Prognosis of screen-detected heart failure with reduced and preserved ejection fraction in patients with type 2 diabetes. Int J Cardiol. 2015;185:162–4.CrossRefPubMed
7.
go back to reference Wilson JM, Jungner YG. [Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam. 1968;65:281–393.PubMed Wilson JM, Jungner YG. [Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam. 1968;65:281–393.PubMed
8.
go back to reference Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263–71.CrossRefPubMed Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263–71.CrossRefPubMed
9.
go back to reference Seferovic PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36:1718–27.CrossRefPubMed Seferovic PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36:1718–27.CrossRefPubMed
10.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefPubMed
11.
go back to reference American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef
12.
go back to reference Ryden L, Grant PJ, Anker SD, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD-summary. Diab Vasc Dis Res. 2014;11:133–73.CrossRefPubMed Ryden L, Grant PJ, Anker SD, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD-summary. Diab Vasc Dis Res. 2014;11:133–73.CrossRefPubMed
13.
go back to reference Rutten GEHM, De Grauw WJC, Nijpels G, et al. The NHG guideline Diabetes mellitus type 2. Huisarts Wet. 2013;56:512–25. Rutten GEHM, De Grauw WJC, Nijpels G, et al. The NHG guideline Diabetes mellitus type 2. Huisarts Wet. 2013;56:512–25.
14.
go back to reference Wermeling PR, Gorter KJ, Stellato RK, de Wit GA, Beulens JW, Rutten GE. Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study). Diabetes Obes Metab. 2014;16:841–9.CrossRefPubMed Wermeling PR, Gorter KJ, Stellato RK, de Wit GA, Beulens JW, Rutten GE. Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study). Diabetes Obes Metab. 2014;16:841–9.CrossRefPubMed
15.
go back to reference Ortiz Tobarra MT, Orozco Beltrán D, Gil Guillén V, Terol Moltó C. Frequency of attendance and degree of control of type-2 diabetic patients]. Aten Primaria. 2008;40:139–44.CrossRefPubMed Ortiz Tobarra MT, Orozco Beltrán D, Gil Guillén V, Terol Moltó C. Frequency of attendance and degree of control of type-2 diabetic patients]. Aten Primaria. 2008;40:139–44.CrossRefPubMed
16.
go back to reference National Collaborating Centre for Chronic Conditions (UK). National clinical guideline for management in primary and secondary care (update) nice clinical guidelines, No. 66. London: Royal College of Physicians; 2008. National Collaborating Centre for Chronic Conditions (UK). National clinical guideline for management in primary and secondary care (update) nice clinical guidelines, No. 66. London: Royal College of Physicians; 2008.
17.
go back to reference Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671–9.CrossRef Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671–9.CrossRef
18.
go back to reference Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.CrossRefPubMed Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.CrossRefPubMed
19.
go back to reference Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035–87.CrossRefPubMed Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035–87.CrossRefPubMed
20.
go back to reference Olafsdottir E, Stefansson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol. 2007;91:1599–601.CrossRefPubMedPubMedCentral Olafsdottir E, Stefansson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol. 2007;91:1599–601.CrossRefPubMedPubMedCentral
21.
go back to reference Zavrelova H, Hoekstra T, Alssema M, et al. Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system West-Friesland, the Netherlands. Diabetes Care. 2011;34:867–72.CrossRefPubMedPubMedCentral Zavrelova H, Hoekstra T, Alssema M, et al. Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system West-Friesland, the Netherlands. Diabetes Care. 2011;34:867–72.CrossRefPubMedPubMedCentral
Metadata
Title
Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change
Authors
L. J. M. Boonman-de Winter
M. J. Cramer
A. W. Hoes
F. H. Rutten
Publication date
01-04-2016
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 4/2016
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-016-0809-7

Other articles of this Issue 4/2016

Netherlands Heart Journal 4/2016 Go to the issue